MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Articles Found

Page: « Previous 1 2 3 4 5 6 7 8 9 10 ... Next »



 Recent Articles   Industry   Published  New Window
FDA Approves Genentech’s Avastin (Bevacizumab) Plus Chemotherapy as a Treatment for Women with Advanced Ovarian Cancer Following Initial Surgery Pharma/BioTech/Nutrition 2018/06/13 More
Greenphire Expands Flexibility of eClinicalGPS to Increase CRO and Sponsor Control Pharma/BioTech/Nutrition 2018/06/13 More
Sartorius Stedim Biotech and Siemens Sign Long-term Cooperation Agreement in the Area of Automation Pharma/BioTech/Nutrition 2018/06/12 More
FDA Approves Genentech’s Rituxan (Rituximab) for Pemphigus Vulgaris Pharma/BioTech/Nutrition 2018/06/07 More
Legend Announces FDA Clearance of IND Application on CAR-T Immuno-cell Therapy for the Treatment of Multiple Myeloma Pharma/BioTech/Nutrition 2018/05/30 More
Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership Pharma/BioTech/Nutrition 2018/05/29 More
European Commission Approves Ipsen’s Cabometyx® for the First-line Treatment of Adults with Intermediate or Poor Risk Advanced Renal Cell Carcinoma Pharma/BioTech/Nutrition 2018/05/17 More
Genentech to Present New Phase III Data for HEMLIBRA in People with Hemophilia A at the World Federation of Hemophilia 2018 World Congress Pharma/BioTech/Nutrition 2018/05/13 More
DSM Announces 4-month Shutdown in H2 2018 to Further Upgrade its Vitamin C Facility in Jiangshan, China Pharma/BioTech/Nutrition 2018/05/02 More
Genentech to Present New Data at AAN Highlighting Extensive Research for Ocrevus and Expanding Neuroscience Pipeline Pharma/BioTech/Nutrition 2018/04/20 More
Sartorius Stedim Biotech and Penn State University Announce Partnership Pharma/BioTech/Nutrition 2018/04/16 More
SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program Pharma/BioTech/Nutrition 2018/04/04 More
Ipsen Receives Positive CHMP Opinion for Cabometyx® (cabozantinib) for the First-line Treatment of Adults with Intermediate or Poor Risk aRCC Pharma/BioTech/Nutrition 2018/03/23 More
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy Pharma/BioTech/Nutrition 2018/03/21 More
Sartorius Stedim Biotech Supports ABL Europe in Successful Completion of Viral Vector GMP Capacity Expansion Pharma/BioTech/Nutrition 2018/03/16 More




Page: « Previous 1 2 3 4 5 6 7 8 9 10 ... Next »

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  RightITnow, Inc.





 
  ©2019 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)